Tactile Systems Technology Inc
Exchange: NASDAQSector: HealthcareIndustry: Medical Devices
Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease by helping them live better and care for themselves at home. Tactile Medical collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year.
Current Price
$24.17
+0.50%GoodMoat Value
$55.36
129.0% undervaluedProfile
Valuation (TTM)
Market Cap$539.66M
P/E26.59
EV—
P/B2.47
Shares Out22.33M
P/Sales1.57
Revenue$343.52M
EV/EBITDA11.14
Tactile Systems Technology Inc (TCMD) Stock Analysis
Market Cap$539.66M
Current Price$24.17
P/E Ratio26.59
Forward P/E—
PEG Ratio-0.69
EPS$0.82
Book Value$9.80
P/B Ratio2.47
TCMD Financial Charts
FCF vs CAPEX
FCFCAPEX
Cash vs Debt
Net Cash: 67M
Revenue
189M
FY19
187M
FY20
208M
FY21
247M
FY22
274M
FY23
293M
FY24
330M
FY25
Net Income
11M
FY19
—
FY20
—
FY21
—
FY22
29M
FY23
17M
FY24
19M
FY25
TCMD 52-Week Range
$9.42
$33.05
50-Day MA: $26.17200-Day MA: $21.93
Did you know?
Net income compounded at 9.7% annually over 6 years.
Tactile Systems Technology Inc (TCMD) Financial Summary
Tactile Systems Technology Inc (TCMD) is a Healthcare company in the Medical Devices industry, listed on NASDAQ. The stock currently trades at $24.17 with a market capitalization of $539.66M.
Key valuation metrics include a P/E ratio of 26.59, price-to-book ratio of 2.47, and EPS of $0.82. The company reports a profit margin of 5.9% and return on equity of 9.3%.
TCMD Key Financial Metrics
| Metric | Value |
|---|---|
| Market Cap | $539.66M |
| P/E Ratio | 26.59 |
| EPS | $0.82 |
| P/B Ratio | 2.47 |
| P/S Ratio | 1.57 |
| EV/EBITDA | 11.14 |
| Profit Margin | 5.9% |
| Return on Equity | 9.3% |
| Debt/Equity | 0.07 |
TCMD Revenue & Earnings History
| Year | Revenue | Net Income |
|---|---|---|
| FY19 | $189.49M | $10.97M |
| FY20 | $187.13M | $-620000.00 |
| FY21 | $208.06M | $-11.81M |
| FY22 | $246.78M | $-17.87M |
| FY23 | $274.42M | $28.52M |
| FY24 | $292.98M | $16.96M |
| FY25 | $329.52M | $19.09M |
Tactile Systems Technology Inc (TCMD) Valuation
Based on GoodMoat's DCF model, Tactile Systems Technology Inc has a fair value estimate of $55.36. At the current price of $24.17, the stock appears 56.3% undervalued relative to our intrinsic value estimate.
TCMD Quality Indicators
Tactile Systems Technology Inc maintains a profit margin of 5.9% and an operating margin of 8.9%. Return on equity stands at 9.3%. The current ratio is 4.03. Debt-to-equity ratio is 0.07.
About Tactile Systems Technology Inc
Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease by helping them live better and care for themselves at home. Tactile Medical collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year.
TCMD Free Cash Flow
Tactile Systems Technology Inc generated $40.43M in trailing twelve-month free cash flow, representing an FCF yield of 7.49%. This strong FCF yield suggests the company generates substantial cash relative to its market value.
TCMD Shares Outstanding
Tactile Systems Technology Inc has 0.02 billion shares outstanding at a share price of $24.17, giving it a market capitalization of $539.66M.